<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Elanco announces UK launch of new treatment for canine osteoarthritis pain</title><link>/b/veterinary-news/posts/elanco-announces-uk-launch-of-new-treatment-for-canine-osteoarthritis-pain</link><description> Elanco has announced that Galliprant (grapiprant), its new treatment for canine osteoarthritis pain, is now available in the UK. 
 Galliprant is a first in a class of drugs called piprants, or non-COX-inhibiting prostaglandin receptor antagonists (PRAs</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>